GSK3B and Insulin resistance: However, in type 2 diabetes mellitus, because of insulin resistance, the GSK‐3β phosphorylation pathway is blocked, liver glycogen synthesis is inhibited, and liver glycogen content decreases, resulting in increased blood sugar concentration.20